Exabis Library
Welcome to the e-CCO Library!
OP016: Potential role of bile acid receptor FXR in microscopic colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP017: Multi-donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo-controlled trial
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP017: Telemedicine enables a safe shift from examination room based care to personalised care for inflammatory bowel disease: a pragmatic randomised multicenter trial with myIBDcoach
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP017: Transanal minimally invasive proctectomy with ileal pouch anal anastomosis (Ta-IPAA) in patients with ulcerative colitis: a cohort study from the TaTME international database
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP018: High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signalling
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP018: Optimal anti-TNF stop week during pregnancy depends on anti-TNF type
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP018: The impact of ‘Crohn’s Disease-TReatment-with-EATing’ diet (CD-TREAT diet) and exclusive enteral nutrition on healthy gut bacteria metabolism
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP019: Correlation of clinical and endoscopic outcomes in patients with active Crohn's disease treated with mongersen (GED-0301)
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP019: Efficacy and safety of oral tofacitinib as induction therapy in patients with moderate-to-severe ulcerative colitis: results from 2 phase 3 randomised controlled trials
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP019: In faecal microbiota transplantation (FMT) for ulcerative colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short-chain fatty acid production are associated with remission (FOCUS study)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP01: Comparison of fecal transplantation, fecal transplantation with the novel UC diet or the UC diet alone for Refractory Mild to Moderate Active Ulcerative Colitis: The CRAFT UC randomized controlled trial
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP01: In-depth characterisation of host genetics and gut microbiome unravels novel host–microbiome interactions in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP01: Sequencing-based gene network analysis reveals a profound role for ferroptosis key gene GPX4 in post-operative endoscopic recurrence in Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP01: Withdrawal of infliximab or anti-metabolite therapy in Crohn’s Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE)
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP02 Impact of therapeutic strategies on intestinal resection rate in paediatric inflammatory bowel diseases: A population-based cohort study over a 24-year period (1988–2011)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP020: Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s disease: interim analysis from the Phase 2 FITZROY study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP020: Recent anti-TNF exposure predicts lower vedolizumab trough concentrations in patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP020: The clinical determinants affect gut microbial profile of inflammatory bowel disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP021: Autologous haematopoietic stem cell transplantation for Crohn’s disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP021: Efficacy and safety of oral tofacitinib for maintenance therapy in patients with moderate-to-severe Crohn’s disease: results of a Phase 2b randomised placebo-controlled trial
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM